Anti-FOXJ2 antibody (ab49160)
- Product nameAnti-FOXJ2 antibodySee all FOXJ2 primary antibodies ...
- DescriptionRabbit polyclonal to FOXJ2
- Tested applicationsWB, ELISA more details
- Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat, Cow, Dog
A region within synthetic peptide: MASDLESSLT SIDWLPQLTL RATIEKLGSA SQAGPPGSSR KCSPGSPTDP, corresponding to N terminal amino acids 1-50 of Human FOXJ2
- Positive controlHepG2 cell lysate
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
- Storage bufferPreservative: None
Constituents: 2% Sucrose, PBS
- Concentration information loading...
- PurityProtein A purified
- Clonality Polyclonal
- Research Areas
Our Abpromise guarantee covers the use of ab49160 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use at a concentration of 0.25 µg/ml. Detects a band of approximately 62 kDa (predicted molecular weight: 62 kDa).
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- FunctionTranscriptional activator. Able to bind to two different type of DNA binding sites. Isoform FOXJ2.L behaves as a more potent transactivator than FOXJ2.S.
- Tissue specificityWidely expressed.
- Sequence similaritiesContains 1 fork-head DNA-binding domain.
modificationsPhosphorylated upon DNA damage, probably by ATM or ATR.
- Cellular localizationNucleus.
- FHX antibodyFork head homologous X antibodyForkhead box J2 antibody
- Forkhead box protein J2 antibodyFOXJ2 antibodyFOXJ2_HUMAN antibody
Anti-FOXJ2 antibody images
Lane 1 : MW ladder
Lane 2 : Anti-FOXJ2 antibody (ab49160) at 0.25 µg/ml
Lane 1 : As above
Lane 2 : HepG2 cell lysate at 10 µg
Lane 2 : HRP conjugated anti-Rabbit IgG at 1/50,000 - 1/100,000 dilution
Predicted band size : 62 kDa
Observed band size : 62 kDa
References for Anti-FOXJ2 antibody (ab49160)
ab49160 has not yet been referenced specifically in any publications.